Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | PBRM1 |
Variant | R941fs |
Impact List | frameshift |
Protein Effect | loss of function - predicted |
Gene Variant Descriptions | PBRM1 R941fs (corresponds to R926fs in the canonical isoform) results in a change in the amino acid sequence of the Pbrm1 protein beginning at aa 941, likely resulting in premature truncation of the functional protein (UniProt.org). R941fs has not been characterized, however, due to the effects of other truncation mutations downstream of R941 (PMID: 28082722), is predicted to lead to a loss of Pbrm1 protein function. |
Associated Drug Resistance | |
Category Variants Paths |
PBRM1 mutant PBRM1 inact mut PBRM1 R941fs |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
XM_005265280 | chr3:g.(52603524_52603525) | c.(2821_2820) | p.R941fs | RefSeq | GRCh38/hg38 |
NM_001405601.1 | chr3:g.(52603524_52603525) | c.(2821_2820) | p.R941fs | RefSeq | GRCh38/hg38 |
NM_001400471.1 | chr3:g.(52603524_52603525) | c.(2821_2820) | p.R941fs | RefSeq | GRCh38/hg38 |
XM_005265283 | chr3:g.(52603524_52603525) | c.(2821_2820) | p.R941fs | RefSeq | GRCh38/hg38 |
NM_001405607.1 | chr3:g.(52603524_52603525) | c.(2821_2820) | p.R941fs | RefSeq | GRCh38/hg38 |
NM_001405571.1 | chr3:g.(52603524_52603525) | c.(2821_2820) | p.R941fs | RefSeq | GRCh38/hg38 |
XM_005265282 | chr3:g.(52603524_52603525) | c.(2821_2820) | p.R941fs | RefSeq | GRCh38/hg38 |
XM_005265279.5 | chr3:g.(52603524_52603525) | c.(2821_2820) | p.R941fs | RefSeq | GRCh38/hg38 |
XM_017006745 | chr3:g.(52603524_52603525) | c.(2821_2820) | p.R941fs | RefSeq | GRCh38/hg38 |
XM_017006746.2 | chr3:g.(52603524_52603525) | c.(2821_2820) | p.R941fs | RefSeq | GRCh38/hg38 |
XM_017006745.2 | chr3:g.(52603524_52603525) | c.(2821_2820) | p.R941fs | RefSeq | GRCh38/hg38 |
XM_005265282.4 | chr3:g.(52603524_52603525) | c.(2821_2820) | p.R941fs | RefSeq | GRCh38/hg38 |
XM_005265279 | chr3:g.(52603524_52603525) | c.(2821_2820) | p.R941fs | RefSeq | GRCh38/hg38 |
XM_005265280.3 | chr3:g.(52603524_52603525) | c.(2821_2820) | p.R941fs | RefSeq | GRCh38/hg38 |
XM_017006746 | chr3:g.(52603524_52603525) | c.(2821_2820) | p.R941fs | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
PBRM1 R941fs | clear cell renal cell carcinoma | no benefit | Nivolumab | Case Reports/Case Series | Actionable | In a clinical study, Opdivo (nivolumab) treatment resulted in progressive disease in a patient with renal clear cell carcinoma harboring PBRM1 R941fs (PMID: 29301960). | 29301960 |